II. Indications
- Home Asthma Management
- Home management is critical in reducing daily symptoms and reducing morbidity and mortality
- Asthma Action Plan
- All Asthma patients should have a written plan to respond to acute worsening Asthma
- Asthma Action Plans are especially important in moderate to Severe Asthma
III. Contraindications: Home Management
- Patients who require immediate medical attention (e.g. emergency department)
- High risk of fatal Asthma attack
- Serious exacerbation signs and symptoms
- Significant breathlessness
- Unable to speak in short phrases
- Accessory Muscle use
- Lethargy
- Peak Expiratory Flow <50%
IV. Approach: Asthma Action Plan
- Individualized written instructions based on personal best reliable symptoms and Peak Expiratory Flow
V. Management: Step 1 - Inhaled Beta Agonist (e.g. Albuterol)
-
Albuterol Trial
- Up to 2 treatments of Albuterol MDI 2-6 puffs each (with 20 minutes interval between each use) OR
- One treatment of Albuterol Nebulizer
- Reassessment after 1 hour
VI. Management: Step 2a - Good Response (Mild) with PEF>80%
- Signs
- No Wheezing, Dyspnea or Tachypnea
- Sustained response to Albuterol for 4 hours
- Pediatric Asthma Score (PAS): 5 to 7
- Home Management
- Albuterol 2-4 puffs every 3-4 hours for 24-48 hours
- Inhaled Corticosteroid increased use (if already using)
- Double dose for 7-10 days OR
- Use an additional dose of Inhaled Corticosteroid for every use of Albuterol
- Growing evidence for increased Inhaled Corticosteroid use in acute exacerbation
- Consider oral Corticosteroids
- Contact medical provider in 48 hours for further management
VII. Management: Step 2b - Incomplete Response (Moderate) with PEF 50-79%
- Signs
- Persistent Wheezing
- Shortness of Breath
- Tachypnea
- Cough
- Chest Tightness
- Pediatric Asthma Score (PAS): 8 to 11
- Home Management
- Albuterol 2-4 puffs q3-4 hours for 24-48 hours
- Oral Corticosteroid
- Adult
- Prednisone 40-60 mg per day divided daily to twice daily for 3-10 days OR
- Depo-Medrol 160 mg IM for single dose
- Equal to Methylprednisolone 160 mg PO x8 days
- Effect may be delayed 48 hours
- Child
- Prednisolone
- Dose: 1-2 mg/kg/day to maximum 60 mg/day for 3-10 days OR
- Dexamethasone
- Dose: 0.3 to 0.6 mg/kg/day PO/IV/IM up to 15 mg for 1-2 days
- Keeney (2014) Pediatrics 133(3): 493-9 [PubMed]
- Prednisolone
- No tapering needed if use less than 2 weeks
- Continue course until Peak Expiratory Flow >70%
- Adult
- Contact medical provider urgently same day for recommendations
VIII. Management: Step 2c - Poor Response (Severe) with PEF <50%
- Signs
- Marked Wheezing
- Shortness of Breath, Cough or Chest Tightness
- Severe distress
- Inhaled Albuterol effect lasts less than 2 hours
- Pediatric Asthma Score (PAS): 12 to 15
- Immediate Management
- AlbuterolInhaler 4-6 puffs every 20 minutes prn
- Start oral Corticosteroids
- Adult: 40 to 60 mg per day divided qd to bid
- Child (choose one)
- Prednisolone 1-2 mg/kg/day to maximum 60 mg/day for 3-10 days
- No tapering needed if use less than 2 weeks
- Dexamethasone
- Dose: 0.3 to 0.6 mg/kg/day PO/IV/IM up to 15 mg for 1-2 days
- Keeney (2014) Pediatrics 133(3): 493-9 [PubMed]
- Prednisolone 1-2 mg/kg/day to maximum 60 mg/day for 3-10 days
- Pursue immediate medical care
- Contact doctor
- Proceed to Emergency Department
- Call 911
IX. Efficacy
- Asthma Action Plans reduce mortality by 70%
X. Resources
- Asthma Action Plan (CDC)
- Asthma Action Plan (NIH)
XI. References
- (1997) Management of Asthma, NIH 97-4053
- (1995) Global Strategy for Asthma, NIH 95-3659
- Gibson (2004) Thorax 59(2): 94-9 [PubMed]
- Pollart (2011) Am Fam Physician 84(1): 40-7 [PubMed]
- Stoloff (1997) Am Fam Physician 56(1):117-26 [PubMed]